NIH-funded research Career grant

Understanding how JNK signaling affects autism and related neurodevelopmental disorders

Official title: Defining JNK-associated neurodevelopmental disorders

Funded at Children's Hosp of Philadelphia · NIH-11383141 · Data updated 2026-11-12

This grant studies how a cellular communication pathway called JNK affects brain development and may explain why some kids develop autism or intellectual disability.

More Neurodevelopmental Disorders research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 1, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$221,400
NIH project number5K08NS140553-02
Project IDNIH-11383141 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with neurodevelopmental disorders related to JNK pathway gene variations or pediatric patients whose condition may be linked to these pathways.

Less likely to help

Patients without JNK-related gene variants or who do not have neurodevelopmental disorders are less likely to benefit.

What this research studies

Researchers will use patient-derived stem cell models to see how changes in JNK pathway genes impact brain cell development. They will also look at a large collection of individuals with rare JNK-related gene variants to find new gene-disease links. The work aims to connect molecular changes to neurodevelopmental outcomes so future therapies can be more precisely targeted. This project focuses on conditions like autism and intellectual disability that begin early in life and can affect people across their lifespan. Results could eventually lead to better molecular diagnoses and personalized treatment ideas.

Why it matters

Potential benefit: If successful, the work could improve understanding of the molecular causes of autism and related disorders, guiding more accurate diagnoses and future targeted therapies.

How similar studies have gone: Preliminary findings show that JNK pathway genes can contribute to NDDs, suggesting this approach is promising but still early in development.

Where this research is happening

  • Children's Hosp of Philadelphia
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Nomakuchi, Tomoki T — Children's Hosp of Philadelphia
  • Study coordinator: Nomakuchi, Tomoki T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.